Current mitochondrial disease treatments are generally small molecule antioxidants that address only symptoms, not the root cause (the mutation itself), so the therapeutic goal is to place backup copies of the 13 mitochondrial genes into the nuclear genome where they can be protected by nuclear protective factors, synthesized in the cytosol, and retargeted to be functional in the oxidative phosphorylation complex.
causalpending
Speaker
Primary speakerEvidence Quote
“current line of treatment...generally small molecules that are often antioxidants and they address only the symptoms...our goal is to place backup copies of these 13 genes in the nuclear genome so that we can protect them using the nuclear protective factors...retarget them to be the correct location within the oxwas relay”
Created: 8/10/2026, 10:46:28 PM
Your notes
Loading notes...